Use of SARP-1 for the treatment and/or prevention of scleroderma
US7341995B2 · kind B2 · utility
0Cited by
6References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2001 |
| Grant date | Mar 11, 2008 |
| Priority date | — |
| Expiry date | Aug 9, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of SARP-1 for the preparation of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.